$327.54
-0.31%Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Weak cash conversion. Significant portion of earnings not converting to cashโreview working capital trends and capital intensity.
Capital-intensive operations require significant reinvestment. Monitor whether CapEx is maintenance or growth-oriented.
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extensionโmonitor closely.
Deteriorating cash generation: Both declining FCF and weak conversion rate signal fundamental challenges. Investigate margin pressure, rising costs, or working capital issues.
HUM โข NYSE
| Humana Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||||||||||
1.2B | 1.2B | 2.5B | 2.8B | 2.9B | 3.4B | 2.7B | 1.7B | 2.4B | 614M | 1.3B | 1.1B | 1.2B | 1.2B | 1.4B | 1.1B | 1B | 647.2M | 833.7M | 487.4M | |
824M | 968M | 917M | 845M | 713M | 616M | 575M | 534M | 485M | 465M | 447M | 449M | 426M | 338M | 303M | 262.9M | 250.3M | 220.4M | 184.8M | 148.6M | |
75M | -192M | -167M | -100M | 15M | 195M | 162M | 194M | 132M | -71M | -2M | -64M | 42M | -80M | 22M | -199M | -26.8M | -22M | -32.7M | 70.1M | |
241M | 207M | 175M | 216M | 180M | 181M | 163M | 137M | 157M | 115M | 109M | 98M | 92M | 82M | 67M | 62.9M | 65.9M | 55.4M | 42.1M | 32.6M | |
375M | 615M | 486M | 290M | -1B | -863M | 14M | 792M | 141M | 66M | -346M | 22M | 71M | 46M | 50M | 57.5M | -19.5M | 97.5M | 37.9M | -1.4B | |
(231M) | (570M) | (997M) | (758M) | (227M) | (1.1B) | (518M) | (631M) | (1.5B) | (916M) | (1.2B) | (1B) | (734M) | (745M) | (874M) | (785M) | (627.2M) | (347.4M) | (443.9M) | (0.0) | |
-1.8B | 154M | 81M | 534M | -556M | 2.1B | 1.7B | -1.2B | 688M | 747M | -616M | -34M | -146M | 315M | 218M | 958M | 112M | -16.1M | 158.5M | 2.4B | |
921M | 3B | 4B | 4.6B | 2.3B | 5.6B | 5.3B | 2.2B | 4.1B | 1.9B | 868M | 1.6B | 1.7B | 1.9B | 2.1B | 2.2B | 1.4B | 982.3M | 1.2B | 1.7B | |
INVESTING ACTIVITIES | ||||||||||||||||||||
-546M | -575M | -1B | -1.1B | -1.3B | -964M | -736M | -612M | -526M | -527M | -523M | -528M | -437M | -410M | -336M | -222.3M | -185.5M | -261.6M | -239.2M | -193.2M | |
-81M | -89M | -233M | (2.4B) | -4.2B | -709M | (542M) | -2.3B | -31M | -7M | (1B) | (54M) | -153M | -1.2B | -226M | -832.5M | -12.4M | -422.9M | -493.5M | -28.1M | |
-6.4B | -8.2B | -7.6B | -6B | -7.2B | -9.1B | -6.4B | -4.7B | -6.3B | -6.6B | -6.7B | -2.9B | -3.3B | -3.2B | -3.7B | -4.6B | -7.2B | -5.7B | -3.5B | -4.3B | |
9.4B | 6.4B | 5.1B | 3.8B | 6.1B | 7.7B | 5.8B | 4.5B | 3.9B | 5.7B | 6.6B | 3.3B | 2.7B | 2.9B | 2.9B | 3.8B | 5.2B | 5B | 3.1B | 3.4B | |
-82M | -461M | 210M | 17M | 26M | 0.0 | -542M | -2.1B | 2M | -828M | 1M | 483M | -554M | -1.6B | 64M | 66K | 313.8M | 871.7M | -682.5M | -570.8M | |
(2.3B) | -3B | -3.5B | -1B | -6.6B | -3.1B | -1.3B | -3.1B | -2.9B | -1.4B | (320M) | -63M | -1.2B | -2B | -1.4B | -1.8B | -1.9B | -498.3M | -1.8B | -1.7B | |
FINANCING ACTIVITIES | ||||||||||||||||||||
-151M | -817M | -1.6B | -2.1B | -79M | -1.8B | -1.1B | -1.1B | -3.4B | -104M | -385M | -872M | -531M | -518M | -541M | -108M | -22.8M | -106.1M | -27.4M | 22.5M | |
533M | 218M | 423M | -1.4B | 3.8B | 1.1B | -423M | 1.2B | 755M | 0.0 | 265M | 1.2B | 0.0 | 972M | -103M | -36M | -100.1M | 147.9M | 325.6M | 844M | |
-430M | -431M | -431M | -392M | -354M | -323M | -291M | -265M | -220M | -177M | -172M | -172M | -168M | -165M | -82M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-151M | -817M | -1.6B | -2.1B | -79M | -1.8B | -1.1B | -1.1B | -3.4B | -104M | -385M | -872M | -531M | -518M | -541M | -108.5M | -22.8M | -106.1M | -27.4M | -26.2M | |
-1.2B | -1.5B | 725M | 2B | -310M | -890M | -511M | -595M | 1.9B | 1B | -260M | -878M | -3M | -375M | -291M | -227.3M | 203.8M | -595.8M | 623.1M | 109.1M | |
-1.2B | -2.5B | -856M | -1.9B | 3B | -2B | -2.3B | -785M | -945M | 732M | -552M | -758M | -702M | -29M | -1B | -371.3M | 80.8M | -554M | 921.3M | 975.6M | |
CASH FLOW SUMMARY | ||||||||||||||||||||
2B | -2.5B | -367M | 1.7B | -1.3B | 619M | 1.7B | -1.7B | 165M | 1.3B | 636M | 797M | -168M | -71M | -296M | 59.5M | -356.8M | -70M | 300.1M | 1B | |
2.2B | 4.7B | 5.1B | 3.4B | 4.7B | 4.1B | 2.3B | 4B | 3.9B | 2.6B | 1.9B | 1.1B | 1.3B | 1.4B | 1.7B | 1.6B | 2B | 2B | 1.7B | 732M | |
4.2B | 2.2B | 4.7B | 5.1B | 3.4B | 4.7B | 4.1B | 2.3B | 4B | 3.9B | 2.6B | 1.9B | 1.1B | 1.3B | 1.4B | 1.7B | 1.6B | 2B | 2B | 1.7B | |
375M | 2.4B | 3B | 3.5B | 920M | 4.7B | 4.5B | 1.6B | 3.5B | 1.4B | 345M | 1.1B | 1.3B | 1.5B | 1.7B | 2B | 1.2B | 720.7M | 985M | 1.5B |
HUM - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | June 01, 2026 | June 01, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 19, 2026 | May 15, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | April 29, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 29, 2026 | April 29, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 20, 2026 | April 16, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 10, 2026 | April 10, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 09, 2026 | March 05, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | March 06, 2026 | April 16, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 02, 2026 | March 02, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 19, 2026 | December 31, 2025 | 2025 |
Continue your HUM research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.